Up Next
0
Disaster du Jour & Sunshine Stocks
Chipmaker Advanced Micro Devices is cutting fiscal Q3 revenue guidance, and NPS Pharmaceuticals is popping after the FDA issued an upbeat preview of its short bowel syndrome drug Gattex, with CNBC's Amanda Drury and Brian Sullivan.
Share
Disaster du Jour & Sunshine Stocks
Chipmaker Advanced Micro Devices is cutting fiscal Q3 revenue guidance, and NPS Pharmaceuticals is popping after the FDA issued an upbeat preview of its short bowel syndrome drug Gattex, with CNBC's Amanda Drury and Brian Sullivan.
Date: 10/12/12
Views: 175
Video by:  CNBC
 
Follow us:
Loading... 1 of 167
Today's Most Watched Videos
Related Videos
Loading... 1 of 56